| 药物洗脱微球经导管动脉化疗栓塞术治疗肝细胞癌进展 |
| |
| 引用本文： | 邓国瑜,马亦龙,赵昌.药物洗脱微球经导管动脉化疗栓塞术治疗肝细胞癌进展[J].中国医学影像技术,2020,36(11):1730-1733. |
| |
| 作者姓名： | 邓国瑜 马亦龙 赵昌 |
| |
| 作者单位： | 广西医科大学附属肿瘤医院介入科, 广西 南宁 530021 |
| |
| 基金项目： | 广西医疗卫生适宜技术开发推广应用项目（S2017092）、广西壮族自治区卫生健康委员会自筹经费科研课题（Z20190664）。 |
| |
| 摘 要： | 肝细胞癌(HCC)是最常见的原发性肝癌之一。经导管动脉化疗栓塞术(TACE)一直被用为中期HCC患者的一线治疗方法,而药物洗脱微球TACE(DEB-TACE)的临床应用近年来亦不断增加。本文对DEB-TACE的药物代谢动力学、微球选择、适应证和禁忌证及疗效评估进展进行综述。
|
| 关 键 词： | 癌 肝细胞 化学栓塞 治疗性 |
| 收稿时间： | 2019/8/11 0:00:00 |
| 修稿时间： | 2020/11/19 0:00:00 |
Progresses of drug-eluting bead transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma |
| |
| DENG Guoyu,MA Yilong,ZHAO Chang.Progresses of drug-eluting bead transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma[J].Chinese Journal of Medical Imaging Technology,2020,36(11):1730-1733. |
| |
| Authors: | DENG Guoyu MA Yilong ZHAO Chang |
| |
| Institution: | Department of Intervention, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, China |
| |
| Abstract: | Hepatocellular carcinoma (HCC) is one of the most common primary liver carcinoma. Transcatheter arterial chemoembolization (TACE) has been used as the first-line treatment for patients with mid-term HCC. In recent years,clinical application of drug-eluting bead TACE (DEB-TACE) kept increasing. The pharmacokinetics, selection of microspheres, indications, contraindications and evaluation on therapeutic effect of DEB-TACE for treatment of HCC were reviewed in this article. |
| |
| Keywords: | carcinoma hepatocellular chemoembolization therapeutic |
|
| 点击此处可从《中国医学影像技术》浏览原始摘要信息 |
| 点击此处可从《中国医学影像技术》下载免费的PDF全文 |
